Metabolic abnormalities of certain nutrients, such as fatty acids, primarily represent downstream consequences of SMN protein deficiency, whereas other nutrients, such as folate and vitamin B12, may function as independent regulatory factors that modulate SMN2 gene expression through epigenetic modifications, thereby affecting disease progression. This evidence concerns the gene SMN2 and hereditary thrombophilia due to congenital protein S deficiency.